Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Genmab A/S Establishes Sponsored Level 1 ADR Program in United States


Friday, 31 May 2013 09:12am EDT 

Genmab A/S announced that the Company has established a Sponsored Level 1 ADR program in the United States. Deutsche Bank Trust Company Americas will act as the depositary bank for the Genmab ADR program. Genmab ADRs are US dollar negotiable certificates representing ordinary Genmab shares; two Genmab ADRs represent one Genmab share. Genmab ADRs can be traded on the US over-the-counter (OTC) market effective May 31, 2013 under the ticker symbol GMXAY. Ordinary Genmab shares are traded on the NASDAQ OMX Copenhagen A/S under the ticker symbol GEN. 

Company Quote

545.5
21.0 +4.00%
24 Apr 2015